More than 120 new Florida laws kick in on Wednesday, July 1. Some are minor changes, but some you need to know now.
AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results